Participants 51 115 5
patients with atrial fibrillation: results from the ATHENA study
Participants 451 576 5
in patiENTs with Atrial fibrillation/atrial flutter (ATHENA), a composite of first CV hospitalization or death from any cause
Participants 791 829 3
patients with atrial fibrillation (AF)
Participants 902 1023 6
4628 patients with a history of paroxysmal/persistent AF and additional risk factors, treated with placebo or dronedarone
